BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9374352)

  • 1. Decision analysis: MIBI imaging of nonpalpable breast abnormalities.
    Hillner BE
    J Nucl Med; 1997 Nov; 38(11):1772-8. PubMed ID: 9374352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.
    Hillner BE; Bear HD; Fajardo LL
    Acad Radiol; 1996 Apr; 3(4):351-60. PubMed ID: 8796686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

  • 4. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.
    Khalkhali I; Villanueva-Meyer J; Edell SL; Connolly JL; Schnitt SJ; Baum JK; Houlihan MJ; Jenkins RM; Haber SB
    J Nucl Med; 2000 Dec; 41(12):1973-9. PubMed ID: 11138681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintimammography with Tc-99m sestamibi.
    Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
    Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies.
    Allen MW; Hendi P; Schwimmer J; Bassett L; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):168-85. PubMed ID: 10967626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
    Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
    J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
    Klaus AJ; Klingensmith WC; Parker SH; Stavros AT; Sutherland JD; Aldrete KD
    AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide-guided stereotactic prebiopsy localization of nonpalpable breast lesions with normal mammograms.
    Khalkhali I; Mishkin FS; Diggles LE; Klein SR
    J Nucl Med; 1997 Jul; 38(7):1019-22. PubMed ID: 9225782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
    Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.
    Chen YS; Wang WH; Chan T; Sun SS; Kao A
    Surg Oncol; 2002 Nov; 11(3):151-5. PubMed ID: 12356511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
    Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
    Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can scintimammography reduce "unnecessary" biopsies?
    Flanagan DA; Gladding SB; Lovell FR
    Am Surg; 1998 Jul; 64(7):670-2; discussion 673. PubMed ID: 9655280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintimammography in the diagnosis of breast cancer.
    Clifford EJ; Lugo-Zamudio C
    Am J Surg; 1996 Nov; 172(5):483-6. PubMed ID: 8942549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
    Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.